Search company, investor...
GoodRx company logo

GoodRx

goodrx.com

Founded Year

2011

Stage

IPO | IPO

Total Raised

$1M

Date of IPO

9/23/2020

Market Cap

2.11B

Stock Price

5.82

About GoodRx

GoodRx (NASDAQ: GDRX) provides health consumers with convenient, affordable prescription drugs through a platform that offers a list and map of prices by brand name and generic versions from both local and mail-order pharmacies. The company also offers information on manufacturer discount cards and ways to save with coupons, price-matching, pharmacy discount plans, and more.

Headquarters Location

233 Wilshire Boulevard Suite 990

Santa Monica, California, 90401,

United States

+1 888 799 2553

Missing: GoodRx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: GoodRx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing GoodRx

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned GoodRx in 6 CB Insights research briefs, most recently on Jan 11, 2023.

Expert Collections containing GoodRx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GoodRx is included in 9 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

P

Pharma Supply Chain

1,359 items

T

Tech IPO Pipeline

568 items

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

D

Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

GoodRx Patents

GoodRx has filed 10 patents.

The 3 most popular patent topics include:

  • Pharmaceutical industry
  • Specialty drugs
  • Drug pricing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/19/2019

1/19/2021

Medical monitoring, Pharmaceutical industry, Hepatotoxins, Dosage forms, Phenols

Grant

Application Date

12/19/2019

Grant Date

1/19/2021

Title

Related Topics

Medical monitoring, Pharmaceutical industry, Hepatotoxins, Dosage forms, Phenols

Status

Grant

Latest GoodRx News

FTC fines GoodRx $1.5M for illegally sharing user data

Feb 3, 2023

GoodRx denies any wrongdoing, saying it fixed the issues three years ago GoodRx is best known for offering patients a free price comparison tool so they can save money on their prescription drugs, presenting them with coupons that they can give to their pharmacist so they can pull up the lowest discount available. Turns out, saving people money on their medications is not the only thing they were doing with that data: according to the FTC , it was also sharing consumers personal health information to companies such as Facebook, Criteo, and Google, all without telling the consumer it was doing so. That's a big no-no and now the company has been fined $1.5 million as a result. According to the FTC allegation, GoodRx not only violated its own policies around sharing health information, but also the Health Breach Notification Rule, which requires vendors of personal health records to notify consumers following a breach involving unsecured information. "Since at least 2017, GoodRx deceptively promised its users that it would never share personal health information with advertisers or other third parties. GoodRx repeatedly violated this promise by sharing sensitive personal health information—including its users’ prescription medications and personal health conditions—with third party advertising companies and advertising platforms like Facebook, Google, and Criteo, and other third parties like Branch and Twilio," wrote the FTC. For example, the company is accused of compiling a list of its users who had purchased certain medications, and then uploading data that included their email addresses, phone numbers, and mobile advertising IDs to Facebook so it could identify their profiles. GoodRx used that information to target those users with ads. On top of that, the FTC also says that the company misrepresented its HIPAA Compliance by displaying a seal at the bottom of its telehealth services homepage that suggested it was complying with the law. In addition, by not notifying consumers it was sharing this data, GoodRx violated the Health Breach Notification Rule. “Digital health companies and mobile apps should not cash in on consumers' extremely sensitive and personally identifiable health information,” Samuel Levine, Director of the FTC’s Bureau of Consumer Protection, said in a statement. “The FTC is serving notice that it will use all of its legal authority to protect American consumers’ sensitive data from misuse and illegal exploitation.” The proposed order still has to be approved by a federal court to go into effect, and if it does then GoodRx will have to take actions to remedy the situation, including requiring user consent before they can share their health information, and for GoodRx" to clearly and conspicuously detail the categories of health information that it will disclose to third parties and prohibits the company from using manipulative designs, known as dark patterns, to obtain users’ consent to share the information." The company will be permanently prohibited from disclosing user health information with applicable third parties for advertising purposes, and will also be required to direct those other apps to delete the consumer health data that it already shared with them, to limit how long it can retain personal and health information according to a data retention schedule, and to put in place a comprehensive privacy program that includes strong safeguards to protect consumer data. Founded in 2011, GoodRx coupons are accepted at over 70,000 retail pharmacies in the United States, Puerto Rico, and the U.S. Virgin Islands; that includes chains like CVS, Walgreens, Kroger, Rite Aid, Costco, and Walmart. The company says it has saved consumers over $40 billion to date and it estimates that it has helped more than 18 million people since 2011. In a  statement , the company pushed back, saying that the FTC was focusing "on an old issue that was proactively addressed almost three years ago, before the FTC inquiry began." "At GoodRx, protecting our users’ privacy is one of our most important priorities. We are thoughtful and disciplined about what information we gather and how and why we use it," wrote GoodRx, which detailed all the ways it say it already addressed the issue at the time. Still, the company is agreeing to pay the fine, rather than fight it. "We do not agree with the FTC’s allegations and we admit no wrongdoing. Entering into the settlement allows us to avoid the time and expense of protracted litigation. We believe that the requirements detailed in the settlement will have no material impact on our business or on our current or future operations," wrote GoodRx.

GoodRx Frequently Asked Questions (FAQ)

  • When was GoodRx founded?

    GoodRx was founded in 2011.

  • Where is GoodRx's headquarters?

    GoodRx's headquarters is located at 233 Wilshire Boulevard, Santa Monica.

  • What is GoodRx's latest funding round?

    GoodRx's latest funding round is IPO.

  • How much did GoodRx raise?

    GoodRx raised a total of $1M.

  • Who are the investors of GoodRx?

    Investors of GoodRx include Silver Lake, Spectrum Equity, Francisco Partners, Founders Fund, SV Angel and 8 more.

  • Who are GoodRx's competitors?

    Competitors of GoodRx include Rx Savings Solutions, Capital Rx, NowRX, Waltz Health, nirvanaHealth, SmithRx, NURX, Hoy Health, 23andMe, Sempre Health and 22 more.

Compare GoodRx to Competitors

Waltz Health Logo
Waltz Health

Waltz Health is a digital health company developing consumer tools that support better-informed decisions on prescription care. Designed for consumers, payers, and pharmacies, the company offers AI-driven marketplaces to lower costs, giving consumers access to better pricing options and more information, while helping payers take control of their pharmacy benefits. The company was founded in 2021 and is based in Chicago, Illinois.

Capital Rx Logo
Capital Rx

Capital Rx offers a platform that oversees prescription benefit plans. The company was founded in 2017 and is based in New York, New York.

Rightway Logo
Rightway

Rightway provides navigation and pharmacy benefits solutions delivered through a consumer-centric app that pairs every member with a live, clinician-led care team.

S
Southern Scripts

Southern Scripts provides pharmacy benefit management (PBM) solutions to ensure that employers have flexibility and control over their benefit plan.

WithMe Health Logo
WithMe Health

WithMe Health is a medication guidance company. Replacing legacy pharmacy benefit managers (PBMs), WithMe uses modern technology and datasets to consistently apply and create engaging, individualized medication experiences for employees.

SmithRx Logo
SmithRx

SmithRx is a pharmacy benefit manager focused on transparency, efficiency and data analytics. The company's proprietary technology infrastructure provides real-time actionable insights that drive cost savings and power clinical services. The company was founded in 2016 and is based in San Francisco, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.